Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $344.4800 (1.32%) ($344.4800 - $344.4800) on Tue. Nov. 19, 2019. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 1.78% (three month average) | | RSI | 70 | | Latest Price | $344.4800(1.32%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN declines -0.2% a day on average for past five trading days. | | Weekly Trend | REGN advances 4.3% a week on average for past two weeks. | | Market Behavior | Rotation from value to growth for large cap. Growth stock rally for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
IBB(58%) XLV(47%) IVW(41%) IWF(40%) QQQ(40%) | | Factors Impacting REGN price | REGN will decline at least -0.89% in a week (0% probabilities).
VIXM(-24%) VXX(-11%) TLT(-5%) TIP(-1%) IGOV(1%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -0.89% (StdDev 1.78%) | | Hourly BBV | 0 () | | Intraday Trend | 0% | | | | | |
|
| 5 Day Moving Average | $343.25(0.36%) | | 10 Day Moving Average | $340.46(1.18%) | | 20 Day Moving Average | $326.43(5.53%) | | To recent high | -1.3% | | To recent low | 26.1% | | Market Cap | $36.525b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |